Medicare Enrolled

Dr. Carl Landgren, MD

Hematology & Oncology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
1475 NW 12TH AVE FL 2, Miami, FL 33136
3052435302
In practice since 2014 (12 years)
NPI: 1972926871 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Landgren from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Landgren? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Landgren

Dr. Carl Landgren is a hematology & oncology in Miami, FL, with 12 years in practice. Based on federal Medicare data, Dr. Landgren performed 452 Medicare services across 161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Landgren received a total of $538,791 from 29 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Landgren is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ 452 Medicare services$ $538,791 industry payments

Medicare Practice Summary

Medicare Utilization ↗
452
Medicare services
Bottom 41% in FL for hematology & oncology
161
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~38 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient, complex (40-54 min)426$116$429
New patient office visit, complex (60-74 min)26$158$660
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$538,791
Total received (2018-2024)
Avg $76,970/year across 7 years
Top 2% in FL for hematology & oncology
29
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$340,350 (63.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152,330 (28.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$46,110 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$97,809
2023
$102,475
2022
$58,731
2021
$80,304
2020
$52,184
2019
$74,400
2018
$72,887

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$166,083
PFIZER INC.
$48,704
Janssen Research & Development, LLC
$43,262
GENZYME CORPORATION
$40,254
Adaptive Biotechnologies Corporation
$31,127
Celgene Corporation
$30,838
GlaxoSmithKline, LLC.
$30,756
Regeneron Pharmaceuticals, Inc.
$22,559
Janssen Scientific Affairs, LLC
$17,248
Janssen Biotech, Inc.
$16,445
E.R. Squibb & Sons, L.L.C.
$14,987
Karyopharm Therapeutics Inc.
$11,744
Merck Sharp & Dohme Corporation
$10,536
The Binding Site Inc.
$9,497
ABBVIE INC.
$8,800
BeiGene USA, Inc.
$7,875
SANOFI-AVENTIS U.S. LLC
$7,000
Takeda Pharmaceuticals U.S.A., Inc.
$6,257
BeiGene, Ltd.
$3,500
AstraZeneca Pharmaceuticals LP
$3,300
Janssen Global Services, LLC
$2,440
AbbVie Inc.
$1,650
Kite Pharma, Inc.
$1,340
Celularity Inc.
$1,000
Genentech, Inc.
$825
AbbVie, Inc.
$550
PFIZER INTERNATIONAL LLC
$117
ModernaTX, Inc.
$67
Tempus AI, Inc
$29
Top 3 companies account for 47.9% of total payments
Associated products mentioned in payments ›
BESPONSA · BLENREP · Blincyto · CD38 · DARZALEX · DUPIXENT · ELREXFIO · EMPLICITI · FREELITE · KEYTRUDA · Kyprolis · NINLARO · Non-Covered Product · Nplate · Pomalyst · Revlimid · SARCLISA · TALVEY · TECVAYLI · VENCLEXTA · Venclexta · XPOVIO · XT CDX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for hematology & oncology in FL.

Equivalent to $119,201 per 100 Medicare services performed
Looking for a hematology & oncology in Miami?
Compare hematology & oncologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
179
Per 100K population
6.7
County median income
$68,694
Nearest hospital
JACKSON HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Landgren is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 2%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Landgren experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Landgren performed 426 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Landgren receive payments from pharmaceutical companies?
Yes. Dr. Landgren received a total of $538,791 from 29 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Landgren's costs compare to other hematology & oncologys in Miami?
Dr. Landgren's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Landgren) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →